Terns Pharmaceuticals (TERN) Earnings Date, Estimates & Call Transcripts $7.25 +0.56 (+8.37%) Closing price 04:00 PM EasternExtended Trading$7.28 +0.04 (+0.48%) As of 05:06 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Terns Pharmaceuticals Earnings Summary Terns Pharmaceuticals issued Q2 2025 earnings on August 5, 2025, reporting an EPS of -$0.26, which topped the consensus estimate of -$0.28 by $0.02. With a trailing EPS of -$1.04, Terns Pharmaceuticals' earnings are expected to decrease next year, from ($1.19) to ($1.35) per share. Upcoming Q3 Earnings DateNov. 11Before Market OpensEstimatedConsensus EPS (Aug. 5) -$0.28 Actual EPS (Aug. 5) -$0.26 Beat By $0.02 Q2 2025 Earnings ResourcesQ2 2025 Earnings Report Press Release (8-K) Quarterly Report (10-Q)TERN Upcoming EarningsTerns Pharmaceuticals' next earnings date is estimated for Tuesday, November 11, 2025, based on past reporting schedules. Powered by Get Terns Pharmaceuticals Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Terns Pharmaceuticals and other key companies, straight to your inbox. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Charts & View Estimated and Actual Earnings DataTERN Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter. Terns Pharmaceuticals Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20251-$0.30-$0.30-$0.30Q2 20251-$0.33-$0.33-$0.33Q3 20251-$0.37-$0.37-$0.37Q4 20251-$0.40-$0.40-$0.40 FY 2025 4 -$1.40 -$1.40 -$1.40 Q1 20261-$0.29-$0.29-$0.29 Terns Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 11/11/2025(Estimated)--------8/5/2025Q2 2025-$0.28-$0.26+$0.02-$0.26--5/8/2025Q1 2025-$0.29-$0.26+$0.03-$0.26--3/20/2025Q4 2024-$0.30-$0.24+$0.06-$0.24--11/12/2024--$0.33-$0.28+$0.05-$0.28--8/5/2024--$0.35-$0.31+$0.04-$0.31--5/13/2024Q1 2024-$0.36-$0.30+$0.06-$0.30--3/14/2024Q4 2023-$0.29-$0.29--$0.29--11/14/2023Q3 2023-$0.31-$0.42 -$0.11-$0.42-- Terns Pharmaceuticals Earnings - Frequently Asked Questions When is Terns Pharmaceuticals' earnings date? Terns Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 11th, 2025 based off last year's report dates. Learn more on TERN's earnings history. Did Terns Pharmaceuticals beat their earnings estimates last quarter? In the previous quarter, Terns Pharmaceuticals (NASDAQ:TERN) reported ($0.26) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.28) by $0.02. Learn more on analysts' earnings estimate vs. TERN's actual earnings. How much profit does Terns Pharmaceuticals generate each year? Terns Pharmaceuticals (NASDAQ:TERN) has a recorded net income of -$88.85 million. TERN has generated -$1.04 earnings per share over the last four quarters. What is Terns Pharmaceuticals' EPS forecast for next year? Terns Pharmaceuticals' earnings are expected to decrease from ($1.19) per share to ($1.35) per share in the next year. More Earnings Resources from MarketBeat Related Companies Organon & Co. Earnings Results Alvotech Earnings Results Centessa Pharmaceuticals Earnings Results ImmunityBio Earnings Results Tarsus Pharmaceuticals Earnings Results Ocular Therapeutix Earnings Results Agios Pharmaceuticals Earnings Results Denali Therapeutics Earnings Results Galapagos Earnings Results IDEAYA Biosciences Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles After Earnings Miss, Walmart Is Still a Top Consumer Staples PlayRoyal Caribbean Earnings Beat Fuels Strong 2025 OutlookDLocal Stock Soars 43% After Earnings Beat and Raised GuidanceGreen Dot's 30% Rally: Turnaround Takes Off on Explosive EarningsElbit Systems Jumps on Record Earnings and a $1.6B ContractBrinker Serves Up Earnings Beat, Sidesteps Cost PressuresWhy BigBear.ai Stock's Dip on Earnings Can Be an Opportunity This page (NASDAQ:TERN) was last updated on 8/26/2025 by MarketBeat.com Staff From Our PartnersThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | SponsoredFed Decision Warning: How to Protect Your Wealth Before September 30th On September 17th, the Fed faces an impossible choice—and Wall Street insiders are already preparing for the...American Alternative | SponsoredElon Musk’s New TechnologyElon Musk is building something in Memphis that could eclipse even Tesla and SpaceX. At the heart of it is a n...Paradigm Press | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Terns Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Terns Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access